Abstract:Abstract Background Extracellular protein-protein interactions (PPIs) play a crucial role in cell-cell adhesion, communication, and signaling. The dysregulation of PPIs in cancer caused by differential protein expression can drive oncogenic factors. Traditional methods to study PPIs disfavor weak or transient interacting protein partners, leaving them undiscovered. Proximity labeling (PL) is an emerging tool in which a catalyst is attached to a protein of interest (POI) and creates reactive species that tag nearby endogenous proteins. Tagged proteins are subsequently isolated and identified as potential interacting partners with the POI. If PL could be activated at a more specific subcellular location, such as the site of a PPI, more detailed information could be unveiled concerning the interactome of cancer-relevant PPIs. Recent advances in PL involve the use of a synthetic catalyst that can be localized to a POI via an antibody or ligand and avoids the need for PL enzyme-POI fusion proteins to be constructed, allowing for analysis of primary tissue samples. Methods To create a PL catalyst with pseudo-allosteric regulation, we created a switchable DNA catalyst. The DNA catalyst is composed of synthetic photocatalyst and quencher moieties covalently linked to DNA oligomers such that when hybridized together the photocatalyst is quenched and inactive. The DNA scaffold affords conformational control that is utilized to change the distance between photocatalyst and quencher, thus regulating photocatalyst activity. Split triggers composed of DNA oligos that bind to catalyst-DNA and simultaneously disrupt quencher-DNA hybridization were used to create an AND logic gate where both split triggers need to be in proximity to activate the PL catalyst. The split triggers were localized to POIs via connection to aptamers, short pieces of synthetic DNA that bind targets. Using the c-Met homodimer as a model system, we first labeled c-Met expressing HEK293T cells with aptamer-split trigger DNA oligomers as well as the quenched photocatalyst. After the catalyst was activated at the site of the PPI, we performed proximity labeling using a biotin-phenol substrate in the presence of an oxidizing agent and 450 nm light. Fluorescent streptavidin was used to visualize sites of biotinylation and detected using fluorescence microscopy. Results We observed extracellular biotin signal only of c-Met transfected cells as evidenced by the expression of a co-transfection plasmid encoding a fluorescent nuclear protein. When one of the split triggers had the aptamer motif removed, meaning it couldn’t be localized to the cell surface, no labeling was observed which shows that both split probes must be localized to the cell surface to activate labeling. Additionally, controls including omission of light, photocatalyst, or biotin phenol showed no labeling. Using a free-floating version of the photocatalyst to label cells, we confirmed that lysates contained biotinylated proteins via western blot. Conclusion We localized two split triggers to interacting proteins to activate a PL catalyst and performed proximity labeling at the site of the PPI. This technique demonstrates non-genetic split proximity labeling to enable downstream analysis of cancer cell proteomes in an ultra-specific manner and expands the toolkit for spatiotemporally controlled proximity labeling.

Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL)

Proximity labeling expansion microscopy (PL-ExM) evaluates interactome labeling techniques

In Vivo Interactome Profiling by Enzyme‐catalyzed Proximity Labeling

Proximity Labeling Expansion Microscopy (Pl-Exm) Resolves Structure of the Interactome

Spatiotemporal photocatalytic proximity labeling proteomics reveals ligand-activated extracellular and intracellular EGFR neighborhoods

Multiscale photocatalytic proximity labeling reveals cell surface neighbors on and between cells

Spatiotemporally-resolved mapping of extracellular proteomes via in vivo-compatible TyroID

A Native Mass Spectrometry Approach to Qualitatively Elucidate Interfacial Epitopes of Transient Protein-Protein Interactions

A New in Vivo Cross-linking Mass Spectrometry Platform to Define Protein–Protein Interactions in Living Cells

Targeting Peptide‐mediated Interactions in Omics

PLIP 2021: expanding the scope of the protein–ligand interaction profiler to DNA and RNA

B-291 Proximity Labeling at Sites of Protein-Protein Interactions Using a Switchable DNA Catalyst

Subcellular Interactomes Revealed by Merging APEX with Cross-Linking Mass Spectrometry

Deciphering molecular interactions by proximity labeling

In vivo cross-linking-based affinity purification and mass spectrometry for targeting intracellular protein-protein interactions

Proximity labeling: an emerging tool for probing in planta molecular interactions

Generic Plug-and-Play Strategy for High-Throughput Analysis of PTM-Mediated Protein Complexes.

Proximity Labeling in Plants

Integrated and Quantitative Proteomic Approach for Charting Temporal and Endogenous Protein Complexes.

Identification of Piperlongumine (PL) as a new E3 ligase ligand to induce targeted protein degradation